AlpInvest Partners’s Agios Pharmaceuticals AGIO Stock Holding History

AlpInvest Partners’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-30,000	Closed	-$1.58M	–	16
2016 Q3	$1.58M	Hold	30,000	–	–	3.96%	3
2016 Q2	$1.26M	Buy	+30,000	New	+$1.48M	2.49%	10
2016 Q1	–	Sell	-4,750	Closed	-$308K	–	29
2015 Q4	$308K	Hold	4,750	–	–	0.51%	25
2015 Q3	$335K	Sell	4,750 -47,541	-91%	-$4.65M	0.66%	26
2015 Q2	$5.81M	Buy	52,291 +29,126	+126%	+$3.14M	7.35%	3
2015 Q1	$2.18M	Buy	+23,165	New	+$2.6M	4.09%	5
2014 Q3	–	Sell	-28,956	Closed	-$1.33M	–	20
2014 Q2	$1.33M	Buy	+28,956	New	+$1.18M	4.73%	7

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AlpInvest Partners's AGIO Position: Q4 2016 in Review

AlpInvest Partners sold out of Agios Pharmaceuticals (AGIO) in Q4 2016, closing a stake of 30,000 shares — an estimated $1.58M sold.

AlpInvest Partners first reported a position in AGIO in Q2 2014 and held it in 7 quarters. The position peaked at $5.81M in Q2 2015. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2016.

AlpInvest Partners reported no remaining Agios Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
AlpInvest Partners sold 30,000 Agios Pharmaceuticals shares in Q4 2016, an estimated $1.58M.
AlpInvest Partners first reported a position in Agios Pharmaceuticals in Q2 2014 and held it in 7 quarters.
AlpInvest Partners's Agios Pharmaceuticals position peaked at $5.81M in Q2 2015.
161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2016.

Based on AlpInvest Partners's 13F filing for Q4 2016, filed 13 Feb 2017.